Other formats:
BibTeX
LaTeX
RIS
@article{1834303,
author = {Taborsky, Milos and Skala, Tomas and Fedorco, Marian and Doupal, Vlastimil and Sovova, Ingrid and Jarkovský, Jiří and Benešová, Klára and Bezdekova, Monika and Vicha, Marek and Danek, Josef and Kautzner, Josef},
article_location = {Olomouc},
article_number = {3},
doi = {http://dx.doi.org/10.5507/bp.2021.071},
keywords = {implantable cardioverter-defibrillator; heart failure; primary prevention; time to shock; sppropriate shock; mortality},
language = {eng},
issn = {1213-8118},
journal = {Biomedical Papers, Olomouc: Palacky University},
title = {Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry},
url = {https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3086},
volume = {167},
year = {2023}
}
TY - JOUR
ID - 1834303
AU - Taborsky, Milos - Skala, Tomas - Fedorco, Marian - Doupal, Vlastimil - Sovova, Ingrid - Jarkovský, Jiří - Benešová, Klára - Bezdekova, Monika - Vicha, Marek - Danek, Josef - Kautzner, Josef
PY - 2023
TI - Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry
JF - Biomedical Papers, Olomouc: Palacky University
VL - 167
IS - 3
SP - 225-235
EP - 225-235
PB - Palacky University
SN - 12138118
KW - implantable cardioverter-defibrillator
KW - heart failure
KW - primary prevention
KW - time to shock
KW - sppropriate shock
KW - mortality
UR - https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3086
N2 - Background. Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation. Methods. Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first Results. A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 +/- 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age >= 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk. Conclusion. In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.
ER -
TABORSKY, Milos, Tomas SKALA, Marian FEDORCO, Vlastimil DOUPAL, Ingrid SOVOVA, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Monika BEZDEKOVA, Marek VICHA, Josef DANEK and Josef KAUTZNER. Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry. \textit{Biomedical Papers, Olomouc: Palacky University}. Olomouc: Palacky University, 2023, vol.~167, No~3, p.~225-235. ISSN~1213-8118. Available from: https://dx.doi.org/10.5507/bp.2021.071.
|
